Recognizing cutaneous drug eruptions reaction patterns provide clues to causes

Postgraduate Medicine

Volumn 104, Issue 1, 1998, Pages 101-115

  Daoud, Mazen S ^a   Schanbacher, Carl F ^a   Dicken, Charles H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; BETA LACTAM ANTIBIOTIC; CURARE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROMYCIN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE AGONIST; PENICILLIN DERIVATIVE; PHENOTHIAZINE DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TETRACYCLINE DERIVATIVE; THIAZIDE DIURETIC AGENT; WARFARIN;

ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; DRUG ERUPTION; DRUG HYPERSENSITIVITY; EPIDERMOLYSIS; ERYTHEMA MULTIFORME; EXFOLIATIVE DERMATITIS; HUMAN; RASH; SERUM SICKNESS; SKIN NECROSIS; STEVENS JOHNSON SYNDROME; URTICARIA; VASCULITIS;

EID: 0031828881     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1998.07.537     Document Type: Article

References (15)

1. Bigby M, Jick S, Jick H, et al. Drug-induced cutaneous reactions: a report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA 1986;256(24):3358-63
2. Slater EE, Merrill DD, Guess HA, et al. Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition. JAMA 1988;260(7):967-70
3. Thompson T, Frable MA. Drug-induced, life-threatening angioedema revisited. Laryngoscope 1993;103(1 Pt 1):10-2
4. Natsch S, Hekster YA, Keyser A, et al. Newer anticonvulsant drugs: role of pharmacology, drug interactions and adverse reactions in drug choice. Drug Saf 1997;17(4);228-40
5. Heckbert SR, Stryker WS, Coltin KL, et al. Serum sickness in children after antibiotic exposure: estimates of occurrence and morbidity in a health maintenance organization population. Am J Epidemiol 1990;132(2):336-42
6. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994;331(19):1272-85
7. Livasy CA, Kaplan AM. Ciprofloxacin-induced toxic epidermal necrolysis: a case report. Dermatology 1997;195(2):173-5
8. Porteous DM, Berger TG. Severe cutaneous drug reactions (Stevens-Johnson syndrome and toxic epidermal necrolysis) in human immunodeficiency virus infection. (Letter) Arch Dermatol 1991;127(5):740-1
9. Bauer KA. Coumarin-induced skin necrosis. (Editorial) Arch Dermatol 1993; 129(6):766-8
10. Gibson GE, Gibson LE, Drage LA, et al. Skin necrosis secondary to low-molecular weight heparin in a patient with antiphospholipid antibody syndrome. J Am Acad Dermatol 1997;37(5 Pt 2):855-9
11. Richard MA, Grob JJ, Laurans R, et al. Sweet's syndrome induced by granulocyte colony-stimulating factor in a woman with congenital neutropenia. J Am Acad Dermatol 1996;35(4):629-31
12. Thibault MJ, Billick RC, Srolovitz H. Minocycline-induced Sweet's syndrome. J Am Acad Dermatol 1992;27(5 Pt 2):801-4
13. Walker DC, Cohen PR. Trimethoprimsulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet's syndrome. J Am Acad Dermatol 1996;34(5 Pt 2): 918-23
14. Arndt KA, Jick H. Rates of cutaneous reactions to drugs: a report from the Boston Collaborative Drug Surveillance Program. JAMA 1976;235(9):918-23
15. Stern RS, Steinberg LA. Epidemiology of adverse cutaneous reactions to drugs. Dermatol Clin 1995;13(3):681-8